Background: Cyanobacterial blooms occur with increasing frequency in freshwater ecosystems, posing a hazard to human and environmental health. Exposure of human to cyanobacterial metabolites occurs mostly via accidental ingestion through contaminated drinking water or during recreational activities and, most frequently, results in gastrointestinal symptoms. Despite the clinical manifestation, cyanobacterial metabolites are rather investigated for their toxicity towards specific organs or tissues, especially hepato-, nephro-, and neurotoxicity, than for effects on the gastrointestinal tract and the associated lymphoid tissue.
Background
Climate change is transforming ecosystems and their composition all over the planet. Among others, temperate climates in the northern hemisphere are experiencing longer and more intense heat periods in summer and increasing CO 2 levels are saturating surface waters with dissolved carbonate. In combination with other anthropogenic factors, such as eutrophication, climate changes have been linked to an increase in frequency and intensity of hazardous cyanobacterial blooms in surface waters [1] [2] [3] [4] .
Cyanobacteria, also known as blue-green algae, are photosynthetic prokaryotes of ancient origin. They are able to produce a large variety of toxic secondary metabolites, cyanotoxins, and heterogeneous in structure, activity, and stability (reviewed in Buratti et al. [5] ). These metabolites can be released to water either directly or upon cell lysis with major implications for the directly affected aquatic species, as well as for human and livestock health. For humans, Fig. 1 illustrates the organs that are traditionally reported as targets of toxicity, as well as other organs/organ systems affected by cyanobacterial toxins.
As reviewed in Wood [6] and Stewart et al. [7] , fatal poisonings of livestock and pets (e.g., dogs) have been reportedly linked to cyanobacterial blooms for decades.
Unlike animals, humans have greater capabilities to access uncontaminated drinking water (underground water or treated surface water) and tend to avoid odorous waters for drinking and recreational activities. Therefore, documented fatal human cases of acute cyanobacteria poisonings have been limited to specific exposure routes, such as hemodialysis treatment with cyanotoxin-contaminated water [8] .
Nevertheless, serious adverse health outcomes have been associated also with other, more common exposure scenarios, and linked to both acute and chronic exposures to toxic cyanobacteria and cyanotoxins. During recreational water activities and sports, humans can be exposed to contaminated water by dermal contact, inhalation, and also ingestion [5] . In the most extreme cases, recreational exposure to cyanobacteria resulted in life-threatening conditions requiring hospitalization, e.g., due to atypical pneumonia [9] , pneumonia followed by dyspnea and liver damage [10] , or an acute hepatic failure requiring a liver transplant [11] . Gastrointestinal symptoms, including abdominal pain, malaise, nausea, vomiting, and diarrhea, were also manifested during these severe poisonings. Interestingly, such gastrointestinal symptoms have been often documented also in the other cases of acute, usually self-limited, adverse health outcomes, which followed recreational contact with cyanobacteria-contaminated water [5, 12, 13] (see also sections below). A prospective epidemiological study found an increased incidence of gastrointestinal illnesses in human populations living in the proximity of cyanobacteria-contaminated lakes, even if their recreational contact with the contaminated water was very limited [14, 15] .
Gastrointestinal irritation and diseases are regularly linked to the occurrence of cyanobacterial blooms, especially to the consumption of cyanobacteria-contaminated drinking water as reported by Levesque et al. [14, 15] and reviewed in Svirčev et al. [12] . Acute poisonings 1 Organs/organ systems affected by toxic metabolites of cyanobacteria. Organs traditionally considered targets of toxicity are on the left; organs directly subjected to oral exposure are on the right. Grey background illustrates organs with mucosal surfaces that serve as primary entry portals for environmental and dietary contaminants. The figure depicts inner organs figuratively and not anatomically correct. Data based on literature review and detailed sources are provided in Tables 2, 3 , and 4. *: putative toxin, in parentheses: effect supported by in vitro data only (no in vivo data available) in a larger scale have been mostly reported upon consumption of insufficiently treated surface water, often following algicidal treatment of cyanobacteria-infested freshwater reservoirs used as drinking water sources [16, 17] . Lysis of cyanobacterial cells upon algicidal treatment releases the intracellular toxic metabolites to the water. While the conventional treatment technologies can eliminate intact toxic cyanobacterial cells effectively, these technologies have limited capability for removal of dissolved cyanobacterial toxins, which allows that these reach human populations via drinking water supplies in sufficiently high concentrations to cause adverse effects in the gastrointestinal system (Table 1) . Chronic exposures to drinking water contaminated with cyanobacterial compounds, in some instances in combination with other confounding factors, have been associated with an increased incidence of liver cancers or chronic liver damage and diseases, as reviewed and discussed by Svirčev et al. [12] , and supported by recent findings [18] [19] [20] . Interestingly, epidemiologic studies have also linked chronic exposures to drinking water contaminated with cyanobacteria and their metabolites to the increased incidence of colorectal or small intestinal cancer in China [21] , Portugal [22] , and Serbia [12, 23] , or stomach cancer mortality in China [24] . Nevertheless, other studies have not observed strong associations between colorectal cancer and (chronic) exposures to toxic cyanobacteria [25] , or found negative correlation for small intestinal cancer [24] .
The gastrointestinal system and its link to the immune system
Upon oral exposure, which is the most relevant route of exposure to cyanobacterial metabolites [47] , gastrointestinal epithelia are the first barrier to be overcome before systemic exposure, and hence, the gastrointestinal tract is a major entry portal for cyanobacteria and their bioactive metabolites into an organism's system. In addition, the gastrointestinal system is highly associated with the immune system. Besides harboring commensal microbiota, ingested foodstuffs, pathogens, and environmental contaminants pass through the intestines which induce the production of many toxic or antigenic compounds that may trigger inflammatory responses. To maintain a homeostatic environment and prevent exaggerated immunological reactions when inappropriate, there are several gut-specific adaptations from all compartments involved: the intestinal epithelium, the gut-associated lymphoid tissue, and the microbiome.
Interactions between the microbiome and the mucosal immune system or the gastrointestinal tract (GIT) play a critical role in the tolerance of intestinal microbiome and its specific antigens by host-defense systems to avoid permanent inflammatory states [48] . There are indications that exposure to the cyanobacterial toxin microcystin-LR alters the taxonomic composition of the microbiome, as well as the expression of functional genes in the GIT of mammals (mice, rats) [49, 50] .
Anatomically, the gastrointestinal passage consists of the esophagus terminating into the stomach that connects via the pylorus to the small intestine (duodenum, jejunum, and ileum in descending order) [51] . While the highly active small intestine is characterized by structured epithelia with maximum surface area, the colon is less structured and lined by a thick mucus layer enabling effective water reabsorption while preventing tissue invasion of the essential commensal microbiota that reside predominantly in this part of the GIT [51, 52] .
How do the GIT and the immune system accomplish the task of protective immunity and pathogen clearance while tolerating commensal microbes and dietary constituents? In the colon, the mucus secreted by the epithelial goblet cells is antimicrobial and, therefore, poses a physical barrier for bacteria ([51] and references therein). The mucus production is controlled by soluble immune mediators also known as cytokines. Cytokines can be secreted by epithelial or immune cells and modulate the immune response. For example, tumor growth factor-beta (TGF-β) and retinoic acid promote regulatory T-cell (Treg) differentiation in the gut, responsible for the homeostatic equilibrium in the intestines to a large extent [52] [53] [54] . On the other hand, pro-inflammatory interleukin (IL) IL-1, IL-6, and tumor necrosis factor-alpha (TNF-α) are released by phagocytic cells upon activation of Toll-like receptors (TLRs) sensing pathogen-associated molecular patterns (PAMPs).
Intestinal phagocytic macrophages residing in the gut mucosa are sessile and they constitutively produce high amounts of (anti-inflammatory) IL-10 enabling them to limit the inflammation via effective scavenging [55] . Meanwhile, dendritic cells are mobile and act as major antigen-presenting cells migrating to secondary lymphoid organs and priming B and T cells that they can be recruited to the gut-associated lymphoid tissue and eventually secrete the protective immunoglobulin A into the lumen [55] .
These integrated mechanisms, spatially restricted to the intestinal proximity, allow the immune system to remain unresponsive to commensal microbiota and dietary constituents in the gut lumen and to launch a robust immune defense reaction when these microorganisms or compounds cross the epithelial barrier and invade tissues and the organism. MCs 19-year-old man practicing jet ski exposed for more than 2 h to a dense cyanobacterial bloom developed gastrointestinal malaise, nausea, vomiting, and muscle weakness a few hours later. His condition worsened during the next 4 days, developed into pulmonary problems and dyspnea, followed by hepatotoxicosis [10] Canada 2009 n.a.
MCs, LPS
Increased incidence of gastrointestinal symptoms (diarrhea, vomiting, eventually nausea, fever, and abdominal cramps) in residents with full recreational contact at cyanobacteriacontaminated lake (swimming, waterskiing, windsurfing, etc.). These symptoms were also reported in cases of limited contact with contaminated water (fishing using watercraft). Significantly higher incidence of various other symptoms (muscle pain, skin symptoms, and ear symptoms) in populations supplied with treated surface water from cyanobacteriacontaminated supplies. The symptoms were correlated with concentrations of lipopolysaccharides [14, 15] 
Microcystin effects
Microcystins (MCs), non-ribosomal cyclic heptapeptides, are the most common toxins in cyanobacterial blooms and the most extensively studied cyanotoxins (reviewed in Testai et al [56] and Buratti et al. [5] ). MCs are synthesized via non-ribosomal polyketide/peptide synthetase multienzyme complexes encoded by the mcy gene cluster. The general structure of MCs is a cyclo
. Adda represents (all-S,all-E)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid, which is a unique feature characteristic for all MCs. Variable l-amino acids can be present in positions 2 and 4, for example leucine (L) and arginine (R), and this structural variant is then called microcystin-LR (MC-LR). More than 240 structural variants of MCs have been reported, differing not only in the amino acids at positions 2 and 4, but also other modifications, such as demethylations of N-methyldehydroalanine, methylaspartic acid, or Adda [57] .
Due to their hydrophilic nature, MCs cannot readily enter the cells of exposed organisms, but require an uptake mechanism. Upon swallowing, MCs overcome the gastrointestinal epithelial barrier and enter blood circulation [58] [59] [60] [61] . Uptake into hepatocytes is facilitated by organic anion transport polypeptides (OATPs) of the bile acid transport system, particularly OATP1B1, 1B3 that are highly expressed in parenchymal hepatocytes, and also by OATP1A2 [62, 63] .
Of the 12 identified OATPs, only few (OATP1B1, 1B3, 2B1, and 1A2) have been extensively studied due to their expression in the tissues recognized as the main target of MCs toxicity [64, 65] . Of these four OATPs, only OATP2B1 that is not involved in the uptake of MCs seems to be functionally relevant in the intestines, while the expression and function of MC-transporting OATP1A2 in the intestines is still being discussed [63] [64] [65] [66] . The expression of OATP1B1 and 1B3 is considered specific to the liver [64] , and hence, their contribution to the intestinal uptake of MCs is probably negligible. Other OATPs functionally expressed in the human intestinal tract are OATP4A1, 3A1, and 2A1; however, these have not been examined for their involvement in MC uptake [63, 64, 67] . Similarly to the GIT, cells of the innate immune system only express a limited set of OATPs. Transcriptomic analyses revealed high expression of OATP2B1 mRNA and lower levels of OATP3A1, 4A1, and 4C1, while no transcriptomic indication for OATP1A1, 1A5, 1B1, 1B2, 1B3, or 1C1 expression in human macrophages was found [68] [69] [70] . Furthermore, functional studies on drug transport via OATP2A1 and 2B1 in human macrophages indicate their functional expression [71, 72] . Moreau et al. [68] also reported intermediate-to-low expression levels of OATP3A1 and 4C1 in monocytes, but their role in MCs cellular uptake is unclear.
Once inside the cells, MCs inhibit the ubiquitous protein phosphatases 1 and 2A (PP1/2A) due to the interaction of Adda-methyldehydroalanine moiety with the catalytic site of the enzyme, including a covalent binding between methyldehydroalanine of MCs and cysteinyl residue at the catalytic site of the enzyme [5] . The consequence of protein PP1/2A inhibition by MCs is hyperphosphorylation of cytoskeletal proteins, disruption of intracellular signaling, inhibition of DNA repair, mitochondrial alternation and oxidative stress, DNA damage, apoptosis, and necrosis induction [5, 73] . Protein phosphatases play a crucial role in the intracellular signaling by dephosphorylating, and thereby deactivating, proteins like Raf, MEK, and AKT (PP2A, action as tumor suppressor) [74] . Furthermore, MC-LR has been shown to stimulate pro-inflammatory cytokine production in murine macrophages (RAW264.7) in a phosphatase-independent manner via activation of TLRs [5, 69] , and promote tumor growth and possibly neoplastic transformation and carcinogenesis [75] [76] [77] .
With more than 240 congeners, MC-LR is considered to be one of the most common, abundant and toxic structural variants, with a median lethal dose (LD50, acute oral toxicity) of 5-mg/kg bodyweight (bw) of orally exposed mice and a no-observed adverse effect level (NOAEL liver ) of 40 µg/kg/day for 13 weeks of repeated dose exposure (chronic toxicity) [2, 47, [78] [79] [80] [81] [82] . Modifications of MC molecules, including modifications of Adda-methyldehydroalanine region as well as other parts, such as variable amino acid residues at positions 2 and 4, can lead to the reduction of PP1/2A inhibition potencies [62, 63, [83] [84] [85] [86] [87] . However, the observed differences in acute in vivo toxicity of MCs [87] cannot be exclusively attributed to the differences in PP1/2A inhibition among different MC variants. OATP-mediated cellular uptake of MCs seems to be also structure-dependent, which contributes to the differences between cytotoxicity of individual structural variants without a clear relationship to PP1/2A inhibition potency [62] . MCs are detoxified by conjugation with glutathione (GSH) which is catalyzed by the activity of biotransformation enzyme glutathione-S-transferase. Reaction is followed by MC-GSH conversion by gamma-glutamyltranspeptidase and then cysteinylglycine dipeptidase into MC-cysteine conjugate. This biotransformation reduces cellular uptake of the toxin and/or facilitates its excretion that most likely occurs via P-glycoprotein or multidrug resistance proteins, and, hence, alters the ability to inhibit PP1/2A and decreases toxicity [85, 88, 89] .
Depending on the MC congener, the dose, and the duration of exposure, MCs cause necrotic, apoptotic, or cell-proliferative changes [90, 91] . Due to the high abundance of OATP1B1 and 1B3 in parenchymal hepatocytes, the high metabolic activity, and detoxifying function, toxic effects often manifest in the liver, even though the first site of action upon water-borne contaminants is probably mucosal epithelia of the GIT (Table 2 ). In fact, oral exposure of mice to MC-LR caused erosion of surface epithelial cells of the small intestine and accumulation of MC-LR in intestinal villi (Table 2 ) [89] . DNA damage in mice intestine and colon after intraperitoneal exposure was reported [92] , as well as increased apoptotic indices in different parts of the murine intestine [93] . In both small and large intestines (caecum), MC-LR was detected in the mucus of goblet cells, indicating the excretion of MCs into the GIT lumen upon blood circulation and exposure of the liver. Similarly, Falconer [94] reported lesions in the liver and the small intestine upon oral administration of MC-containing water to pigs. Furthermore, not only epithelial lesions but also decrease in intraepithelial lymphocytes in the intestine was shown in a murine model [95] . Moreover, changes in the activity of membrane enzymes and in the peroxidation status in rat intestine were proven [96] .
Besides uptake from the GIT, lesions of the small intestine (i.e., the jejunum) have been reported in mice upon intraperitoneal exposure, indicating toxic mechanisms of the MC-LR excretion into the GIT [93] . Thus, in addition to the liver, the intestines should also be considered a target of MC toxicity [97, 98] . Besides acute effects on animals and human colon-derived cell lines, the intestines can be dietary exposed to low doses of MCs, so chronic exposure may adversely affect intestinal tissue [98] .
To better mimic the human GIT and to account for interspecies extrapolation, a limited number of experiments on human gut-derived cell lines, especially the human colon carcinoma-derived cell line CaCo-2, which exhibits properties of the small intestine upon in vitro differentiation, were conducted [99] . Zegura et al. [98] even observed a comparable sensitivity of CaCo-2 and hepatic HepG2 cells to MC-LR exposure. Studies with CaCo-2 cells confirm a rapid uptake of MC-LR in apical-basolateral direction over a CaCo-2 monolayer [100] and indicate the susceptibility of intestinal epithelia to MC toxic effects, as observed in aforementioned in vivo studies [93] . Among others, cytotoxicity of MCs is accompanied by oxidative stress (lipid peroxidation induction, reactive oxygen species production, reduced glutathione content, etc.) and cytokine production [97] . Interestingly, MC-LR induced the same levels of IL-6 but much higher levels of IL-8 than MC-RR in CaCo-2 cells after 24-h exposure [101] . Transcriptomic analysis showed quite similar profiles induced by MC-RR and MC-LR, but overall gene expression was higher in the case of MC-LR [102] . Interestingly, the uptake of these two congeners does not differ in CaCo-2 cells and both of them are able to enter into the nucleus [103] . Furthermore, MCs cytotoxicity could depend also on the presence of more hydrophobic amino acids in the molecule. The more hydrophobic congeners MC-LF and MC-LW displayed higher cytotoxicity in CaCo-2 cells in comparison to MC-LR [91] .
Microcystin also plays a role in neoplastic transformation in intestinal cells. It constitutively activates AKT and p38, and JNK and MAPK pathways in human-immortalized colorectal crypt cells (NCC) which leads to their proliferation and anchorage-independent growth phenotype [77] . MC-LR also increases the migrative and invasive potential of HT-29, DLD-1 and SW480 human colon cell lines [104] . Higher migration and tissue invasion of HT-29 cells after MC-LR treatment are also connected with an increase in cadherin-11 expression [105] . Furthermore, MC-LR decreases E-cadherin expression and increases the expression of vimentin and Snail in DLD-1 and HT-29 cells promoting epithelial-mesenchymal transition [75] . A recently published study shows the ability of MC-LR to contribute to the migration of DLD-1 cells via changes in microRNA-221 expression and STAT3 phosphorylation [106] .
Besides reports of effects on gastrointestinal and hepatic cells, MC-LR is suspected to alter the immune response, especially in fish, in which most of the studies addressing immunotoxic effects have been done [107] [108] [109] [110] [111] . For example, exposure to MC-LR affected the immune response of medaka fish and induced sustained pathological changes in the GIT, liver, and other organs [108] . Using mouse as a mammalian in vivo model, MC-LR has been shown to decrease levels of intraepithelial lymphocytes, thus affecting mucosal immunity [95] . In vitro exposure of murine macrophages to MC-LR significantly altered the expression of pro-inflammatory genes and the release of cytokines (Table 2) [69, 112] . Adamovsky et al. [69] additionally proposed a receptor (TLR)-mediated mechanism of macrophage activation. As their model lacked specific transmembrane transporters (OATPs), the common mode of MC-LR uptake and action cannot be taken into regard. Besides the tumorpromoting potential of MCs, chronic inflammation itself plays an important role in early carcinogenesis, which, thus, may act synergistically with MC tumor promotion and neoplastic transformation potential and promote tumor progression [113] . This is of special importance considering a reported tumor-promoting and neoplastic transformation potential of MCs [75-77, 82, 114] .To summarize the effects of MCs, we conclude that MCs pose a hazard to the human GIT and the associated 
Cylindrospermopsin effects
Cylindrospermopsin (CYN), a tricyclic guanidine alkaloid was first characterized in Cylindrospermopsis raciborskii [119] upon a major intoxication event in Palm Island, Australia [16] . Despite the still not entirely elucidated molecular mode of action, CYN is proven to be a potent inhibitor of protein synthesis (LOEC = 0.5 µM CYN, primary mouse hepatocytes) [5, 120, 121] . In addition, CYN has been found to induce tissue damage, cytotoxic effects, oxidative stress, and DNA damage in a variety of organs and cell types [as reviewed in 120] . CYN toxicity was reported to be attenuated by different inhibitors of cytochrome P450 (CYP450) in vivo [122] , as well as in the cultured cells in vitro [121, [123] [124] [125] [126] [127] . Induction of CYP450 activity also increased CYN toxicity in hepatic cell lines [121, 126, 128] . Thus, it has been proposed that CYP450 activity is responsible for CYN bioactivation, increasing especially CYN-induced acute cytotoxicity, oxidative stress, and genotoxicity, while inhibition of protein synthesis appeared to be unaffected and attributed to the parental compound [121, 125] . However, no biotransformation products of CYN have been detected upon incubation with S9 liver fraction or in the presence of metabolically competent liver cell lines [127] , in addition, the S9 liver fraction was not found to increase genotoxic potential of CYN in the other studies [129, 130] . Thus, the exact role of CYP450 in CYN toxicity is not completely clear and should be investigated in the future [120] . Phase II detoxification of CYN is supposedly mediated via glutathione conjugation and excretion in the liver and kidney [5, 120, 124, 127, 128] . These detoxifying and excreting organs are also the most sensitive tissues (NOAEL = 30 µg/kg/day; in mice) and the major recipients of CYN toxicity, but adverse effects on the stomach, the small intestine, and on white blood cells have also been reported [131] [132] [133] .
CYN exposure led to elevated markers of inflammation and diminished the uptake of bacteria into phagocytes in the common carp (Cyprinus carpio) [109] . Although there are significant differences between immune systems of different groups of animals, vertebrates share some common mechanisms of innate immune system activation. These first-line defense mechanisms are, amongst others, increased expression of pro-inflammatory cytokines (e.g., IL-6 and TNFα), production of reactive oxygen species (ROS), secretion of nitric oxide, and phagocytosis [69, [134] [135] [136] . Recently, it was elucidated that CYN activates murine macrophages in vitro [137] . In addition, CYN (0.1 µg/L; 0.24 µM) has been shown to significantly decrease lymphocyte proliferation in vitro in both isolated T-cell culture and a whole-blood assay [138] .
Due to the hydrophilic zwitterionic nature of CYN, similarly to MCs, it probably cannot be readily absorbed from the gastrointestinal tract upon ingestion, the main pathway of human exposure, and hence, it has been hypothesized to require a facilitated or active transport [139, 140] . Exposure of mice to CYN-induced ulcers in the stomach, and bleeding into the stomach and small intestine (Table 3) [133]. Nevertheless, there is a lack of research addressing the gastrointestinal effects of CYN. Only two studies on colon-derived tumor cells (CaCo-2) address uptake kinetics across the intestinal epithelium, both reporting only a limited passage of the toxin through the intact epithelium [99, 141] . Pichardo et al. concluded that paracellular diffusion is the most likely uptake mechanism of CYN from the intestinal lumen, while active transport via P-glycoprotein or multidrug resistance proteins probably contributes to the secretion and elimination of CYN [141] . Despite the observed in vitro uptake across the epithelial barrier of intestinal cells, CYN causes oxidative stress and decreases the viability of CaCo-2 cells in a dose-dependent manner ( Table 3) , highlighting that enterocytes, as well as hepatocytes, also should be considered a major important recipient of CYN toxicity, especially upon oral exposure [142] .
Lipopolysaccharide effects
Like most of the commensal and pathogenic bacteria, cyanobacteria are usually Gram-negative bacteria (i.e., do not stain purple with Gram's stain). However, although there is an overall Gram-negative structure, the peptidoglycan is thicker in cyanobacteria compared to Gramnegative bacteria [147] . This group of microbes shares a common structural feature: they incorporate lipopolysaccharides (LPSs) in their cell wall. Eubacterial LPS are known as a model ligand of the Toll-like receptor 4 (TLR4), a member of pattern recognition receptor (PRR) family expressed on epithelial, endothelial, immune (particularly macrophages and dendritic cells), and other cells being an important part of the innate immunity [148] [149] [150] . To maintain homeostasis in exposed tissues, activation of PRRs may launch a robust immune reaction, eventually preventing the invasion of microbes into other tissues of a healthy individual [151, 152] . Cyanobacterial LPS was for the first time isolated and analysed by Weise and colleagues [153] . Later, some cyanobacterial LPS, e.g., from M. aeruginosa, Anabaena cylindrica, and Oscillatoria brevis, were shown to be lethally toxic for mice [154, 155] . Moreover, different human health effects connected with cyanobacterial LPS were published, including irritation of GIT, skin, eyes, and the respiratory tract. Furthermore, headache, dizziness, and fever were observed (reviewed in [156] ).
Although the effects of Escherichia coli LPS are stronger, LPS from blooms and cultured strains of M. aeruginosa as well activates NF-κB in human immune cells and subsequently leads to the production and release of pro-inflammatory cytokines [157, 158] . On the other hand, LPS have also showed anti-inflammatory properties. LPS extracted from Oscillatoria planktothrix FP1 (so-called CyP) has been shown to selectively antagonize LPS from bacteria via binding to MD-2 protein [159] . CyP inhibits the production of pro-inflammatory cytokines and affects microRNA expression in different in vitro models [160, 161] .
The different biological potential of LPS from various sources can be connected to its structural variation [162, 163] . For example, keto-deoxyoctulosonate and heptoses are absent in LPS produced by Anabaena spp. and its lipid A lacks phosphorylation and glucosamine, while being acylated at up to ten sites [155, [164] [165] [166] . Altered acylation of LPS significantly influences the magnitude of LPS inflammatory potential with hexaacylation triggering the strongest pro-inflammatory responses [162, 167] .
One of the first and most widespread human acute health effects upon (accidental) ingestion and intoxication of cyanobacterial bloom material is gastrointestinal illness, often with severe inflammatory diarrhea (enterocolitis) [6, 12, 14, 168] . In the gastrointestinal epithelial layer, which is constantly exposed to a large variety of LPSs, the expression of functional TLR4 is low [169, 170] . Despite this fact, LPS isolated from cyanobacterial bloom or selected cultured strains is able to activate intestinal epithelial cells in vitro (Šindlerová, unpublished data). Phagocytic immune cells found in the submucosal lamina propria are then activated as well as other immune cells trafficking to the place of inflammation [167, 171, 172] . These immune cells express TLR4 and can be activated by LPS crossing the mucosal/epithelial barrier due to the increased permeability of inflamed epithelia [167] . In vitro studies show for example that LPS from M. aeruginosa blooms and strains activates blood cells, namely human polymorphonuclear leukocytes and monocytes, which are involved in the innate immune defense [157, 158] . Furthermore, rat microglia were shown to be activated by LPS from different cyanobacterial species [173] [174] [175] . Taken together, these studies indicate that not only intestinal but also immune cells can be affected by cyanobacterial LPS.
Despite the controversy on the inflammatory potential of cyanobacterial LPS, Stewart et al. [156] identified that there is even a lack of evidence to support the gastrointestinal pro-inflammatory reaction of heterotrophic bacterial LPS alone, in the absence of other virulence factors. Considering the pro-inflammatory potential of cyanobacterial bloom extracts, including the bloomassociated heterotrophic bacteria, a cumulative action of several (cyano-) bacterial compounds is very likely [156, 157, 164, 176, 177] . For example, LPS may contribute to local GIT tissue inflammation and thereby facilitate the access of other toxic compounds, like MCs, to deeper tissues and distribution to other organs and targets of toxicity such as the liver [176] .
Other toxins
Nodularins (NODs) are cyclic non-ribosomal pentapeptide toxins, produced almost exclusively by Nodularia spumigena, that share structural and mechanistic similarities with MCs: non-proteinogenic amino acids like N-methyldehydrobutyrine and d-erythro-β-methylaspartic acid are incorporated into the peptide ring structure and the ADDA residue mediates toxicity [5 and references therein]. Nodularia spumigena is favored in slightly saline environments; therefore, besides MCs, NOD is a major concern in the Baltic Sea and other brackish habitats [178, 179] . Few data are available on NOD toxicokinetics, but a similar uptake mechanism (OATP) and mode of action (PP1 and PP2A inhibition) to MCs are proposed and partly supported by experimental evidence in zebrafish and different hepatic cell lines [5, 180, 181] . In addition, NOD has an experimental LD50 of 50-70 µg/kg bw of rodents, which is similar to that of MC-LR (40-µg/kg bw) [2, 5] . Therefore, NODs can be expected to cause adverse effects similar to MCs on the GIT. Despite severely inhibiting activity of PPs, NOD in contrast to MCs does not bind covalently to these ubiquitous cytoplasmic enzymes [182] .
The cyanobacterial neurotoxins anatoxin-a, anatoxina(S), and saxitoxin are fast acting compounds, leading to paralysis and eventually respiratory failure within minutes to few hours [183, 184] . Due to the rapid onset and specificity of neurological symptoms induced by inhibiting the transfer of excitatory signals, gastrointestinal irritation is unlikely to be a primary effect of these toxins. Nevertheless, exposure to complex cyanobacterial blooms encompasses a mixture of various cyanobacterial, bacterial, and even xenobiotic and anthropogenic compounds. These may modulate the toxic effects of single compounds and result in gastrointestinal symptoms. An overview of enterotoxic effects linked to cyanobacterial blooms is given in Table 4 .
Except of the well-recognized cyanotoxins, there are many potentially harmful bioactive secondary metabolites poorly characterized. Many of these metabolites, like the non-ribosomal peptides aeruginosins, anabaenopeptins, or cyanopeptolins, have protease inhibiting activities, the latter has been also shown to cause neurotoxic effects and alter pathways linked to DNA damage and repair (Table 4) [185] [186] [187] [188] [189] [190] .
Another group of poorly characterized cyanobacterial secondary metabolites are cyclic lipopeptides. Representatives of this group are, for example, anabaenolysins and puwainaphycins that cause damage to eukaryotic cell membranes in GIT models and induce necrotic effects (Table 4 ) [191] [192] [193] . More explicit effects on the GIT are reported by Humpage et al. [194] . They described necrotic effects of the novel putative toxin "limnothrixin", isolated from Limnothrix spp., upon oral gavage of an aqueous extract, in liver, kidney, and GIT tissue within 24-h exposure (Table 4) . Even though no known toxin was detected in the aqueous extract, there may be the presence of a variety of hydrophilic compound contributing to the effects observed.
The toxicological implications of these activities remain to be elucidated and the characterization of novel putative toxins in an effect-directed screening approach along with the description of structural characteristics should be highly encouraged. Regardless of the unknown toxic potential, these substances may contribute to the severity of gastroenteritis upon cyanobacterial intoxication, for example, by facilitating enteric hemorrhage through interference with the blood coagulation cascade [186] .
Co-action of different factors on the GIT
While single-agent toxic effects are often reported for detoxifying organs like the liver or the kidneys in toxicological studies, the most prominent symptom of harmful algal bloom intoxication is enterocolitis, probably mediated by co-action of multiple virulence factors. Besides the occasionally high abundance of identified cyanobacterial toxins, like MCs, many of the secondary compounds produced by cyanobacteria and eventually released to the water are unidentified or poorly characterized concerning their toxicity (Table 4) [176, 195, 196] . Furthermore, bloom-associated bacteria may contribute to the adverse effects observed upon exposure to cyanobacterial blooms, especially gastrointestinal illness [44, 197] . The complex composition of cyanobacterial blooms also leaves space for additive or even synergistic effects of the diverse compounds, which may exacerbate the impact of exposure to otherwise moderately active/toxic compounds.
Also the role of LPS originating from both cyanobacteria and eubacteria has to be critically reflected. The controversies about pro-or anti-inflammatory activities of cyanobacterial LPS may be explained by the effects of bloom-associated bacterial LPS, potentially sensitizing GIT epithelia for the effects of other toxins. A similar effect was observed with the pore-forming lipopeptides anabaenolysins A and B, where a transient increase in cell membrane permeability facilitated nodularin uptake, lowering the effective concentration for nodularin toxicity [191] . Cyanobacterial LPS activity on the mucosal innate immune system does not sufficiently explain the GIT symptoms observed upon acute oral exposure to cyanobacterial blooms. However, the total bloom LPS released during a bloom, including pro-inflammatory LPS from bloom-associated bacteria, may facilitate the penetration of gastrointestinal epithelia and thereby promote the uptake of other cyanobacterial toxins by macrophages or into the blood via the paracellular route as suggested for CYN [141, 156] .
Considering the described activity of MC-LR as a tumor promoter and the suspicion of CYN carcinogenicity, the mixture of substances with diverse biological activity could finally contribute to colorectal cancer incidents upon long-term exposure to low concentrations, e.g., in drinking water [21, 75, 77, 198] .
Summary and future research perspectives
Cyanobacterial blooms are occurring more frequently and with increasing severity due to global climate change and eutrophication of water bodies, endangering the recreational value of water bodies as well as the safety of drinking water supplies. Hazards linked to cyanobacterial contamination have been recognized and addressed by regulatory authorities (WHO, EFSA, and EPA). For cyanobacterial bloom management, the precautionary principle is proposed, which means that the bloom is considered hazardous until proven safe [185] .
Despite gastrointestinal symptoms being the most reported and widespread malaise upon oral exposure to cyanobacterial blooms, research mostly focuses on specific organ toxicity of isolated toxins, i.e., hepatotoxic MCs and CYN. Upon oral exposure, the most relevant route of exposure for humans, the gut epithelium is exposed to the highest toxin concentrations, and it is the first barrier that needs to be overcome for the toxins to reach the blood stream and, subsequently, be distributed to other organs/recipients of toxicity such as the liver. However, gastrointestinal and immunomodulatory effects have not been addressed sufficiently yet, including data allowing for quantitative assessments of doseresponse relationships for acute and chronic adverse outcomes in the GIT in response to individual components of water blooms or their complex mixtures. Regarding cyanobacterial effects on the immune system, we need a thorough investigation of mechanistic effects. Currently, effects to the mucosal immune system are predominantly reported as morphologically altered lymphoid follicles and changes in spleen size or weight during in vivo studies, but the underlying mechanisms are not investigated or discussed any further [120, 133] . The findings summarized in this review need to be elaborated on and verified in a human health relevant system, as most studies are done in fish. Disturbances in the immunological equilibrium including prolonged inflammation may pave the way for other chronic conditions, including carcinogenesis [113] .
There is a significant data gap concerning (chronic) oral exposure to cyanobacterial bloom components, which may be covered by epidemiological studies paired with extensive monitoring for cyanobacterial toxin and bloom-associated compounds' abundance in water reservoirs and drinking water supplies. Furthermore, sensitive subpopulations like children and people with chronic gastrointestinal inflammations (e.g., Crohn's disease) are at higher risk which needs to be reflected by risk assessment studies. These groups suffer more often and from more severe enteritis, as their mucosal immune system is still under development or in a permanently inflamed state. In addition, with regard to the carcinogenic and genotoxic potential of MCs and NODs, low-level chronic exposure may contribute to colon carcinoma in later years [13, 113, 132, 168] .
Conclusion
In the naturally occurring complex mixture of cyanobacterial bloom material, multiple factors can contribute to the adverse effect observed on the GIT and the associated mucosal immune system, probably not attributable to a single toxin or agent. Nevertheless, even isolated toxins are reported to adversely affect the small intestine (MC-LR and CYN) or the stomach (CYN), highlighting the importance of further investigation of this relevant system. MC-LR, for which the scarce evidence on GIT irritation is strongest, should even be reconsidered as an enterotoxin. We summarize evidence of inflammatory processes linked to cyanobacterial bloom exposure that may have a significant impact on chronic diseases, such as cancer-especially as some cyanotoxins (MCs) exhibit carcinogenic properties that may be synergistically enhanced by chronic inflammation.
To address the data gaps, we call for more comparable monitoring data to allow statistical (meta-) analyses and conclusive correlation of cyanobacterial blooms and health outcomes for further risk assessment studies.
Materials and methods: description of workflow
To obtain relevant scientific literature, a systematic review of publications was performed according to the PRISMA scheme (Preferred Reporting Items for Systematic reviews and Meta-Analyses; online Additional file 1: Figure S1 ). The Scopus database, including PubMed, Web of Knowledge, and Science Direct, was searched for the keywords: (TITLE-ABS-KEY (cyanobacteria OR cyanotoxins OR microcystins OR bloom*) AND TITLE-ABS-KEY (epidemiology OR incidence OR health OR health AND effects OR health AND risk OR health AND impact OR health AND hazard OR adverse AND effects OR risk AND assessment OR exposure OR drinking AND water OR intoxication OR disease OR illness) AND TITLE-ABS-KEY (gastrointestinal OR gastro* OR enteric OR allerg* OR gastric OR inflamm* OR lps OR lipopolysacch*). No further limits (Access type, publication date, document type etc.) were defined; all results were in English language (last searched on December 13, 2018). 87 articles were identified through the database search; 55 additional articles were identified by other sources. After removing duplicates (n = 16), 126 articles were screened for eligibility based on the abstracts. Forty-four publications were not eligible on the basis of their abstracts and eighty two underwent further full-text assessment. Of these, 66 articles were included for review purposes.
Titles classified as highly relevant (i.e., review articles and epidemiological studies) indicated further sources, not found by searching the Scopus database.
This review elaborates and expands on five review articles identified as highly relevant [4, [6] [7] [8] [9] . 
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